drugset / Trial / NCT06944379
ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose
RandomizedParallel-groupDouble-blindOther
Summary
This is a Phase 1, first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of ORKA-002 in healthy participants.
Timeline
- Start
- 2025-05-19
- Primary completion
- 2027-01
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORKA-002 | Unknown | — | Subcutaneous |
Indications
No indication recorded.